These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system. Feinstein DL; Kalinin S; Braun D J Neurochem; 2016 Oct; 139 Suppl 2():154-178. PubMed ID: 26968403 [TBL] [Abstract][Full Text] [Related]
3. Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis. Polak PE; Kalinin S; Feinstein DL Brain; 2011 Mar; 134(Pt 3):665-77. PubMed ID: 21297130 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review. Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973 [TBL] [Abstract][Full Text] [Related]
5. Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity. Counts SE; Mufson EJ J Neurochem; 2010 May; 113(3):649-60. PubMed ID: 20132474 [TBL] [Abstract][Full Text] [Related]
6. Conditional Depletion of Hippocampal Brain-Derived Neurotrophic Factor Exacerbates Neuropathology in a Mouse Model of Alzheimer's Disease. Braun DJ; Kalinin S; Feinstein DL ASN Neuro; 2017; 9(2):1759091417696161. PubMed ID: 28266222 [TBL] [Abstract][Full Text] [Related]
7. The locus coeruleus neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer's disease. Braun D; Feinstein DL Brain Res; 2019 Jan; 1702():29-37. PubMed ID: 29274883 [TBL] [Abstract][Full Text] [Related]
8. Marked dopaminergic cell loss subsequent to developmental, intranigral expression of glial cell line-derived neurotrophic factor. Chun HS; Yoo MS; DeGiorgio LA; Volpe BT; Peng D; Baker H; Peng C; Son JH Exp Neurol; 2002 Feb; 173(2):235-44. PubMed ID: 11822887 [TBL] [Abstract][Full Text] [Related]
9. The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleus. Polak PE; Kalinin S; Braun D; Sharp A; Lin SX; Feinstein DL J Neurochem; 2012 Apr; 121(2):206-16. PubMed ID: 22288774 [TBL] [Abstract][Full Text] [Related]
10. Crucial role of TrkB ligands in the survival and phenotypic differentiation of developing locus coeruleus noradrenergic neurons. Holm PC; Rodríguez FJ; Kresse A; Canals JM; Silos-Santiago I; Arenas E Development; 2003 Aug; 130(15):3535-45. PubMed ID: 12810600 [TBL] [Abstract][Full Text] [Related]
11. Beta-amyloid-dependent expression of NOS2 in neurons: prevention by an alpha2-adrenergic antagonist. Kalinin S; Polak PE; Madrigal JL; Gavrilyuk V; Sharp A; Chauhan N; Marien M; Colpaert F; Feinstein DL Antioxid Redox Signal; 2006; 8(5-6):873-83. PubMed ID: 16771677 [TBL] [Abstract][Full Text] [Related]
13. Noradrenergic regulation of inflammatory gene expression in brain. Feinstein DL; Heneka MT; Gavrilyuk V; Dello Russo C; Weinberg G; Galea E Neurochem Int; 2002 Nov; 41(5):357-65. PubMed ID: 12176079 [TBL] [Abstract][Full Text] [Related]
14. The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease. Kalinin S; Polak PE; Lin SX; Sakharkar AJ; Pandey SC; Feinstein DL Neurobiol Aging; 2012 Aug; 33(8):1651-63. PubMed ID: 21705113 [TBL] [Abstract][Full Text] [Related]
15. The noradrenergic system is necessary for survival of vulnerable midbrain dopaminergic neurons: implications for development and Parkinson's disease. Hassani OK; Rymar VV; Nguyen KQ; Huo L; Cloutier JF; Miller FD; Sadikot AF Neurobiol Aging; 2020 Jan; 85():22-37. PubMed ID: 31734438 [TBL] [Abstract][Full Text] [Related]
16. Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects: implications for Parkinson's disease. O'Neill E; Harkin A Neural Regen Res; 2018 Aug; 13(8):1332-1337. PubMed ID: 30106035 [TBL] [Abstract][Full Text] [Related]